Previous studies indicated that IL‐6 inhibition could ameliorate intestinal permeability in DSS‐induced colitis through the reduced expression of the intestinal tight junction protein, claudin‐2 (Xiao et al., 2016). This evidence concerns the gene CLDN2 and colitis.